Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Botulinum toxin type A
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Xeomin 100unit powder for solution for injection vials
0409030B0BEAAAE
|
Xeomin | Botulinum toxin type A | Central Nervous System | 37 |
|
Botox 200unit powder for solution for injection vials
0409030B0BCACAG
|
Botox | Botulinum toxin type A | Central Nervous System | 25 |
|
Botulinum toxin type A 100unit inj vials
0409030B0AAAEAE
|
Botulinum toxin type A | Botulinum toxin type A | Central Nervous System | 15 |
|
Botox 100unit powder for solution for injection vials
0409030B0BCAAAE
|
Botox | Botulinum toxin type A | Central Nervous System | 3 |
|
Xeomin 200unit powder for solution for injection vials
0409030B0BEACAG
|
Xeomin | Botulinum toxin type A | Central Nervous System | 3 |
|
Botox 50unit powder for solution for injection vials
0409030B0BCABAD
|
Botox | Botulinum toxin type A | Central Nervous System | 2 |
|
Botulinum toxin type A 50unit inj vials
0409030B0AAADAD
|
Botulinum toxin type A | Botulinum toxin type A | Central Nervous System | 1 |
|
Xeomin 50unit powder for solution for injection vials
0409030B0BEABAD
|
Xeomin | Botulinum toxin type A | Central Nervous System | 1 |
|
Azzalure 125unit powder for solution for injection vials
0409030B0BFAAAF
|
Azzalure | Botulinum toxin type A | Central Nervous System | No data available |
|
Bocouture 100unit powder for solution for injection vials
0409030B0BGABAE
|
Bocouture | Botulinum toxin type A | Central Nervous System | No data available |
|
Bocouture 50unit powder for solution for injection vials
0409030B0BGAAAD
|
Bocouture | Botulinum toxin type A | Central Nervous System | No data available |
|
Botulinum toxin type A 125unit inj vials
0409030B0AAAFAF
|
Botulinum toxin type A | Botulinum toxin type A | Central Nervous System | No data available |
|
Botulinum toxin type A 200unit inj vials
0409030B0AAAGAG
|
Botulinum toxin type A | Botulinum toxin type A | Central Nervous System | No data available |
|
Botulinum toxin type A 300unit inj vials
0409030B0AAAHAH
|
Botulinum toxin type A | Botulinum toxin type A | Central Nervous System | No data available |
|
Botulinum toxin type A 500unit inj vials
0409030B0AAAAAA
|
Botulinum toxin type A | Botulinum toxin type A | Central Nervous System | No data available |
|
Dysport 300unit powder for solution for injection vials
0409030B0BBABAH
|
Dysport | Botulinum toxin type A | Central Nervous System | No data available |
|
Dysport 500unit powder for solution for injection vials
0409030B0BBAAAA
|
Dysport | Botulinum toxin type A | Central Nervous System | No data available |
|
Letybo 50unit powder for solution for injection vials
0409030B0BHAAAD
|
Letybo | Botulinum toxin type A | Central Nervous System | No data available |
|
Vistabel 50unit powder for solution for injection vials
0409030B0BDAAAD
|
Vistabel | Botulinum toxin type A | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.